NCT02111083View on ClinicalTrials.gov

A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

Insulin Lispro

LY275585 administered SC.

Trial Locations (1)

117597

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02111083 - A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants | Biotech Hunter | Biotech Hunter